Packaging of Pharmaceuticals and Healthcare Products
|
|
- Tyler McCarthy
- 6 years ago
- Views:
Transcription
1 Packaging of Pharmaceuticals and Healthcare Products H. LOCKHART Professor, School of Packaging Michigan State University Associate Director Center for Food Pharmaceutical Research Member of Packaging Sub-Committee Committee of Revision U.S. Pharmacopeial Convention and F.A. PAINE Adjunct Professor School of Packaging Michigan State University Consultant Packaging Technology & Management with invited contributions from M.I. ROBERTSON, R.R EVANS and J. GARBETT BLACKIE ACADEMIC & PROFESSIONAL An Imprint of Chapman & Hall London Glasgow Weinheim New York Tokyo Melbourne Madras
2 Contents 1 Introduction to the packaging of Pharmaceuticals and healthcare products 1 Introduction Definition 1 Types of product 2 Ethical medicines 2 Proprietary medicines 4 Other classifications 4 Drug development and design 6 The design process 7 Newer drug delivery systems i() Inhalation therapies '2 References ' 2 2 Spoilage mechanisms 13 Spoilage agents ' The effects of moisture '3 The effects of light and oxygen '5 The effect of heat 16 Other factors IX Mechanical hazards of transport '8 Climatic hazards of distribution -" Biological hazards of distribution 21 Good distribution practice (GDP) Other hazards References 3 Packaging requirements of Pharmaceuticals 25 The origin of drugs Drugs of vegetable and animal origin 25 Synthetic drugs 26 Materials of mineral origin -" Solid preparations - Moisture protection of solid oral preparations 2S Abrasion of solid oral preparations Selection of containers Unit dose packaging Semi-solid (UK) or semi-liquid/viscous (USA) preparations -V Packages for semi-solid preparations * Liquid pharmaceutical preparations - ^ Aqueous oral preparations Aqueous non-oral preparations - "
3 viii CONTENTS Non-aqueous liquids References 4 Developing packaging for medical preparations 42 Introduction T" The packaging decision making process 42 Materials and structure of the package ^3 Sterilisation of materials 43 Package structure ^2 Packaging line engineerin g " Line efficiency " Labelling, text and graphics requirements " Legislative requirements for the packaging of medical preparations 58 Statutory requirements ^8 General manufacturing considerations 62 The packaging specification 62 References 63 APPENDIX 64 Trouble-shooting on-line 64 Introduction: Limitations of the human eye/brain system in high-speed inspection 64 Practical applications 66 Summary 67 5 Licensing considerations regarding the immediate packaging of Pharmaceuticals for human use 68 Introduction 68 Sources of official guidance 68 Licence applications 69 Influence of pharmacopoeias 70 Plastic containers 71 Rubber components of the container 72 The application dossier 73 Container-brief description (Part II. A.2) 73 Development pharmaceutics (Part II. A.4) 73 Packaging material (PartU.C.3) 74 Stability tests on the finished product (Part II.F.2) 75 Master files 76 Medicinal formulation/packaging compatibility 78 Stresses from manufacturing procedures 78 Toxicological investigations 79 Prior use 80 Environmental issues - implications for packaging 80 Labelling 82 Variations 84 Medical devices 87 Problem solving 88 Pre-fillcd syringes 88 Dry powder inhalers 89 Form-fill-seal technique 89 Other plastic packaging/medicinal formulation interactions 90 Glass packaging/medicinal formulation interaction 91
4 CONTENTS IX Closures 91 Metered-dose inhalers 92 Topical metered dosing 92 Pumps for nebulisers 92 Transdermal patches 93 Printing inks and adhesives 93 Two-compartment syringes 93 Two-compartment syringe 94 Moisture ingress 94 References 95 6 Primary and intermediate packages 98 Introduction 98 Major packaging types used 98 ' Primary packaging 99 Glass 99 Plastic containers 101 Use of plastics in pharmaceutical packaging 108 Methods of producing plastic forms 108 Closures for glass and plastic containers 120 '" The general requirements for a good seal 121 v Secondary functions of closures 125 Metal and plastic collapsible tubes 126 Methods of production 1 28 Types of collapsible tube 130 Sealing tubes '31 Types of closure and methods of closing 131 Intermediate packages 132 Common carton styles 133 Folding boxboard cartons '35 7 Quality Assurance for packaging in the pharmaceutical industry 138 Introduction '38 Quality assurance - the component specifications 139 Quality assurance - the QC test specification ' 41 Conformance testing ' "*- Sampling l4 7 Supplier audits I4!S Bibliography 1M) 8 Child-resistant packaging ^1 Introduction Historical background Testing procedures Definitions V Some typical styles of CR packaging ;/ References? * Appendix 1 Extracts from European Protocol pren862 '-M Appendix 2 Revision of US Protocol 17()
5 X CONTENTS 9 Tamper-evident packaging 172 Definition History of tamper-evident packaging 173 The Tylenol case 175 Open or closed retail systems 177 Is tampering a societal problem? 179 Performance standards 181 Conclusions 182 Bibliography 183 Appendix Extracts from the FDA Compliance Policy Guides Packaging of healthcare products 188 Introduction 188 Definition of a medical device 189 Package types 190 Pouches 190 Vented bags 193 Preformed tray/lid packages 193 Thermoform/fill/seal (blister) packages 193 Sterilisation 194 Packaging materials 197 Closure 203 Opening healthcare packaging 203 Summary 204 Further reading 204 Index 206
Pharmaceutical Packaging
Pharmaceutical Packaging 2017 2021 Section I: Introduction A. Pharmaceuticals defined B. Pharmaceutical packaging defined C. Study organization D. Methodology E. Geographic regions F. Conventions Section
More informationPharmaceutical Packaging
Pharmaceutical Packaging 2017 2021 Section I: Introduction A. Pharmaceuticals defined B. Pharmaceutical packaging defined C. Study organization D. Methodology E. Geographic regions F. Conventions Section
More informationPharmaceutical Packaging Products
INDUSTRY MARKET RESEARCH FOR BUSINESS LEADERS, STRATEGISTS, DECISION MAKERS CLICK TO VIEW Table of Contents 2 List of Tables & Charts 3 Study Overview 4 Sample Text, Table & Chart 5 Sample Profile, Table
More informationHow to Avoid Common Deficiencies in INDs and NDAs. Ramesh Raghavachari, Ph.D. Branch Chief, Branch IX ONDQA/OPS/CDER
How to Avoid Common Deficiencies in INDs and NDAs Ramesh Raghavachari, Ph.D. Branch Chief, Branch IX ONDQA/OPS/CDER 1 Structure of FDA Office of Commissioner Chief Scientist FOODS Medical Products & Tobacco
More informationGUIDELINES FOR INTRODUCING A LOCALLY MANUFACTURED NEW PHARMACEUTICAL PRODUCT ON THE UGANDA MARKET
GUIDELINES FOR INTRODUCING A LOCALLY MANUFACTURED NEW PHARMACEUTICAL PRODUCT ON THE UGANDA MARKET National Drug Authority Head Office Rumee Towers Plot 19, Lumumba Avenue P. O. Box 23096 Kampala, Uganda
More informationGUIDELINE ON DOSSIER REQUIREMENTS FOR TYPE IA AND TYPE IB NOTIFICATIONS July 2003
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market : management & legislation for consumer goods Pharmaceuticals : regulatory framework and market authorisations Final Revision 0 NOTICE TO
More informationExtractables & Leachables. Ophthalmic Drug Products: A Regulatory Perspective Current Industry Challenges and Case Studies
Extractables & Leachables Ophthalmic Drug Products: A Regulatory Perspective Current Industry Challenges and Case Studies Ph.D. Pfizer Global Research and Development Bethesda 23/02/2011 Thresholds and
More informationFormulation Development & CTM Manufacturing Services
Formulation Development & CTM Manufacturing Services VxP Pharma Purdue Research Park 5225 Exploration Drive Indianapolis, IN 46241 Tel: 317.759.2299 Fax: 317.713.2950 VxP Pharmaprovides an extensive range
More informationCONVENIENCE FOR PATIENTS
the dermal experience Co-Development CONVENIENCE FOR PATIENTS The dermal delivery route is well established. Millions of patients globally rely on delivery systems for topical and systemic treatments administered
More informationPartner with the Global Leader in Drug Delivery Systems
3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems Northridge, CA, USA Manufacturing Facility Experts at Commercializing Innovation 3M: Transforming New Ideas into Thousands
More informationOn the Q&A to the Guideline for Common Technical Documents
To: Public Health Bureau Prefectural Government Letter from PFSB/ELD 22 nd October 2001 From: Evaluation & Licensing Division, Pharmaceutical & Food Safety Bureau, The Ministry of Health, Labour and Welfare
More informationDEVELOPMENT PHARMACEUTICS AND PROCESS VALIDATION
DEVELOPMENT PHARMACEUTICS AND PROCESS VALIDATION Guideline Title Development Pharmaceutics and Process Validation Legislative basis Directive 75/318/EEC as amended Date of first adoption April 1988 Date
More informationContract Manufacturing Services for Pre-filled Syringes
Contract Manufacturing Services for Pre-filled Syringes From Standard Solutions to Complex Products Stefan Czvitkovich, PhD Director Product Partnering Sterile Pharmaceuticals Central Europe CPhI woldwide
More informationThe GCC Guidelines for Stability Testing of Drug Substances and Pharmaceutical Products EDITION TWO 1428 H 2007 G
The GCC Guidelines for Stability Testing of Drug Substances and Pharmaceutical Products EDITION TWO 1428 H 2007 G (1) INTRODUCTION The following guideline defines the stability data package for a drug
More informationProduct Inspection. Advanced Product Inspection Solutions Supporting System Suppliers and Integrators
Product Inspection Advanced Product Inspection Solutions Supporting System Suppliers and Integrators Product Inspection Solutions Enhanced Solutions Providing Additional Customer Value The inclusion of
More informationHigh Performance ABS Products for Medical Applications
High Performance ABS Products for Medical Applications ELIX Polymers is a leading manufacturer of ABS (Acrylonitrile-Butadiene-Styrene) resins and derivatives in Europe. Compromise Operating from its head
More informationCATALOG & TOOLING BOOK. Go Blister!
CATALOG & TOOLING BOOK Go Blister! INTRODUCTION Dear Customer, I appreciate the opportunity to introduce EW Packaging and would like to thank you in advance for your time and consideration in viewing our
More informationMedical Device Packaging 2017 to 2021
Medical Device Packaging 2017 to 2021 Section I: Introduction A. Medical device packaging defined B. Medical device packaging defined 1. Medical devices defined 2. Combination devices 3. Medical device
More informationOrange and Yellow Guides
PHARMACY PREPARATION ACROSS EUROPE IS THERE A LEVEL PLAYING FIELD? Dr. Alison M.Beaney Regional Quality Assurance Specialist North-East England PHARMACY PREPARATION ACROSS EUROPE IS THERE A LEVEL PLAYING
More informationDownstream handling and Secondary Packging for BFS containers some considerations
Downstream handling and Secondary Packging for BFS containers some considerations Peter Åkerman Senior Advisor AstraZeneca, Sweden Operations Content Regulatory requirements Examples of downstream handling
More informationMedicine Variations Guideline
Medicine Variations Guideline National Health Regulatory Authority (NHRA) Kingdom of Bahrain 30 th March 2017 Version 2.0 Chief of Pharmaceutical Product Regulation: Dr/Roaya Al Abbasi Date: NHRA CEO Approval:
More informationMedicines Variations Guideline
Medicines Variations Guideline National Health Regulatory Authority (NHRA) Kingdom of Bahrain 27/08/2014 Version 1.1 Chief of Pharmaceutical Product Regulation: Dr / Roaya Al Abbasi Date: NHRA CEO Approval:
More informationExtractables and leachables: An Introduction
Extractables and leachables: An Introduction Tim Hulme Smithers Rapra THulme@smithers.com 44(0)1939 252 418 1 Extractables and leachables: An Introduction Tim Hulme Smithers Rapra thulme@smithers.com 2
More informationAPPLICATION FOR VARIATION TO A MARKETING AUTHORISATION
Page 1 of 13 May 2008 APPLICATION FOR VARIATION TO A MARKETING AUTHORISATION HUMAN VETERINARY NATIONAL AUTHORISATION IN MRP MRP variation number 1A : / / / / / COMMUNITY AUTHORISATION EMEA variation number
More information1. Checklist for Grant of permission to manufacture/import of Bulk Drug already approved in the country
1. Checklist for Grant of permission to manufacture/import of Bulk Drug already approved in the country S no 1. Name of Applicant with address 2. Name of Drug 3. Therapeutic Class 4. Date of Approval Documents
More informationPackaging technology. Fundamentals, materials and processes. Edited by. Anne Emblem and Henry Emblem WOODHEAD PUBLISHING
Packaging technology Fundamentals, materials and processes Edited by Anne Emblem and Henry Emblem Recommended by the IOM3 Training Academy and endorsed by The Packaging Society WP WOODHEAD PUBLISHING i
More informationPrequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer
Part 1: General information Name of Manufacturer Production Block Physical address Contact address Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer. Clean Utilities in the Basement.
More informationPhase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017
Phase Appropriate GMPs for IMPs Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 1 Lets start with References https://mhrainspectorate.blog.gov.uk/2016/0 5/20/manufacture-of-investigationalmedicinal-products-frequently-askedquestions/
More informationFOOD AND DRUGS AUTHORITY
G H A N A FOOD AND DRUGS AUTHORITY GUIDELINES FOR STABILITY TESTING OF ACTIVE PHARMACEUTICAL INGREDIENTS AND FINISHED PHARMACEUTICAL PRODUCTS Document No: FDA/DRI/DER/GL-STP/2013/07 Date of First Adoption:
More informationTechnical requirements to Good Manufacturing Practice in metered dose inhalers production and development (2. part) Extractable - Leachable
Technical requirements to Good Manufacturing Practice in metered dose inhalers production and development (2. part) Extractable - Leachable Dr. Gyula Körtvélyessy UNIDO Honorary Secretary General of the
More informationA Unique Resource. Pharmaceutical Healthcare Medical Device Nutraceutical VMS Diagnostics
A Unique Resource Pharmaceutical Healthcare Medical Device Nutraceutical VMS Diagnostics A Unique Resource Pharmaceutical Healthcare Medical Device Nutraceutical VMS Diagnostics Chester Medical Solutions
More informationGuidance for Industry
Guidance for Industry Submission of Documentation in Drug Applications for Container Closure Systems Used for the Packaging of Human Drugs and Biologics DRAFT GUIDANCE This guidance document is being distributed
More informationMedical Device Packaging 2009 to 2013
Medical Device Packaging 2009 to 2013 Section I: Introduction A. Study purpose B. Medical devices defined C. Medical device packaging defined D. Study organization E. Geographic regions F. Study methodology
More informationICH Topic M 4 Q Location issues for Common Technical Document for the Registration of Pharmaceuticals for Human Use Quality Questions and Answers
European Medicines Agency August 2003 CPMP/ICH/4680/02 ICH Topic M 4 Q Location issues for Common Technical Document for the Registration of Pharmaceuticals for Human Use Quality Questions and Answers
More informationA GUIDELINE ON DOSSIER REQUIREMENTS FOR TYPE I VARIATIONS November 1999
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Pharmaceuticals and cosmetics Final Revision 0 NOTICE TO APPLICANTS A GUIDELINE ON DOSSIER REQUIREMENTS FOR TYPE I VARIATIONS November 1999 This guideline
More informationPharmaceutical Facilities
500 Pharmaceutical Facilities Design, Layouts and Validation Prof. Manohar A. Potdar Department of Quality Assurance Poona College of Pharmacy Bharati Vidyapeeth University Pune-411038 India PharmaMed
More informationI. HOD -WORKS: ANNEXURE - A INCHARGE - PRODUCTION: 3. ENGINEERING MAINTENANCE. 1 c (04/12/2014) ---- ~Emath - Job ~hart(~f~fts).
1 c (04/12/2014) ---- ~Emath - Job ~hart(~f~fts).doc Page I * - ANNEXURE - A I. HOD -WORKS: a) To provide adequate manpower and machinery for smooth Functioning of production activities. b) Authorising
More informationA Unique Resource. Pharmaceutical Healthcare Medical Device Nutraceutical VMS Diagnostics
A Unique Resource Pharmaceutical Healthcare Medical Device Nutraceutical VMS Diagnostics A Unique Resource Pharmaceutical Healthcare Medical Device Nutraceutical VMS Diagnostics Chester Medical Solutions
More informationAnnex 10. Stability testing of active pharmaceutical ingredients and finished pharmaceutical products. Introduction and background
Annex 10 Stability testing of active pharmaceutical ingredients and finished pharmaceutical products Introduction and background The guidance on Stability testing of active pharmaceutical ingredients and
More informationANNEX V ASEAN GUIDELINES ON STABILITY STUDY AND SHELF-LIFE OF HEALTH SUPPLEMENTS
Association of South East Asian Nations (ASEAN) ANNEX V ASEAN GUIDELINES ON STABILITY STUDY AND SHELF-LIFE OF HEALTH SUPPLEMENTS Disclaimer: This document is provided for information purpose only and subject
More informationRely on strength: Silgan Closures.
C L O S U R E S Rely on strength: Silgan Closures. Need to close something? Silgan White Cap invented it safe; reliable; efficient. More than 80 years ago we first took the market by storm with our trailblazing
More informationGLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE
GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE Finished Pharmaceutical Product Questionnaire This questionnaire is used to collect information from vendors with regards to finished pharmaceutical products
More informationVaccine Assessment for Prequalification and Programmatic Suitability for Prequalification
Vaccine Assessment for Prequalification and Programmatic Suitability for Prequalification Dr Drew Meek Prequalification Team/Vaccines Assessment Regulation of Medicines and other Health Technologies World
More informationGUIDELINES FOR SUBMISION OF POST- APPROVAL VARIATION MEDICINE APPLICATIONS
GUIDELINES FOR SUBMISION OF POST- APPROVAL VARIATION MEDICINE APPLICATIONS FOOD, MEDICINE AND HEALTH CARE ADMINSTRATION AND CONTROL AUTHORITY OF ETHIOPIA (EFMHACA) First Edition December, 2015 Table of
More informationMedicines Control Authority of Zimbabwe
EFV... QUALITY INFORMATION SUMMARY (QIS) FOREWORD The Quality Information Summary (QIS) template should be completed to provide a condensed summary of the key quality information for product dossiers (PDs)
More informationExtractable and Leachable Challenges From a generic injectable drug development perspective
Extractable and Leachable Challenges From a generic injectable drug development perspective Andrea Redd Director, US Regulatory Affairs Fresenius Kabi November 8, 2017 Disclaimer This presentation contains
More informationStreamflow Measurement
Streamflow Measurement Second edition Reginald W. Herschy Partner, CNS Scientific & Engineering Services Reading, UK E & FN SPON An Imprint of Chapman & Hall London Glasgow Weinheim New York Tokyo - Melbourne
More informationGuidelines on procedures and data requirements for changes to approved biotherapeutic products. Proposed guidelines
0 0 0 0 WHO/PAC for BTPs_DRAFT/ Oct 0 ENGLISH ONLY Guidelines on procedures and data requirements for changes to approved biotherapeutic products Proposed guidelines NOTE: This document has been prepared
More informationModern Processing, Packaging and Distribution Systems for Food
Modern Processing, Packaging and Distribution Systems for Food Modern Processing, Packaging and Distribution Systems for Food Edited by FRANK A. PAINE, B.Sc., C.Chem., F.R.S.C., F.I.F.S.T., F. Inst. Pkg
More informationGLOBAL QUALITY SOLUTIONS PACKAGE INTEGRITY SEAL INTEGRITY LEAK DETECTION
GLOBAL QUALITY SOLUTIONS PACKAGE INTEGRITY SEAL INTEGRITY LEAK DETECTION Redefining the standards for accuracy and reliability. About PTI PTI Packaging Technologies & Inspection is headquartered in Tuckahoe,
More informationWarfarin suspension. Group B Presentation
Warfarin suspension 200mcg/ml Group B Presentation Group B - members Lene, Denmark Nihal, Turkey Jaldaz, FYROM, Mark, UK Matjaz, Slovenia Vincentas, Lithuania Juraj, Slovakia Our Business Provide service
More informationPQRI Workshop: Leachables and Extractables
PQRI Workshop: Leachables and Extractables Rockville, Maryland December 5-6, 2005 Best Practices Recommendation: Regulatory Science Strategies Guirag Poochikian, Ph.D. Office of New Drug Quality Assessment
More informationMINISTRY OF HEALTH AND SOCIAL SERVICES
MINISTRY OF HEALTH AND SOCIAL SERVICES NAMIBIA MEDICINES REGULATORY COUNCIL POST REGISTRATION AMENDMENT GUIDELINES These guidelines are meant to provide assistance to industry and health care professionals
More informationDURA COAT COMBISEALS DATWYLER S NEXT GENERATION IN ALUMINIUM
DURA COAT COMBISEALS DATWYLER S NEXT GENERATION IN ALUMINIUM In this article, Carina Van Eester, Global Platform Leader, Prefilled Syringes & Cartridges, Datwyler Sealing Solutions, covers the advantages
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 3826-3 First edition 2006-09-15 Plastics collapsible containers for human blood and blood components Part 3: Blood bag systems with integrated features Poches en plastique souple
More informationWHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products
WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products 1. Introduction 1.1 Objectives of these guidelines 1.2 Scope of these guidelines 1.3 General principles
More informationAIMCAL R2R Conference 11/15/2018 1
Coating Line Operations for the Production of Drug-Containing Transdermal Patches Presented by: Ken Glade Director of Engineering LTS Lohmann Therapy Systems Kenneth.glade@lts-corp.com +1 (973) 396-5384
More informationDerivation and Justification of Safety Thresholds
Derivation and Justification of Safety Thresholds Douglas J. Ball, MS, DABT Chair, PQRI L&E Toxicology Subgroup Research Fellow, Safety Sciences - Pfizer, Inc. Agenda Basic Definitions Current Regulatory
More informationDraft agreed by Quality Working Party 7 June Adopted by CHMP for release for consultation 28 June 2018
1 13 November 2018 2 EMA/CHMP/CVMP/QWP/496873/2018 3 4 Committee for Medicinal Products for Human Use (CHMP) 5 Committee for Medicinal Products for Veterinary Use (CVMP) 6 7 8 Draft Draft agreed by Quality
More informationGuideline on the label design for Injections (Draft for Comments)
Guideline on the label design for Injections (Draft for Comments) 2018.3 Content Foreword... 3 1. Scope... 4 2. Terms and definitions... 4 3. Basic requirements for labels... 4 4. Design principles of
More informationPolymer Microscopy. Second edition LINDA C. SAWYER. and. DAVID T. GRUBB Cornell University Ithaca, NY USA. Hoechst Celanese Corporation Summit, NJ USA
Polymer Microscopy Second edition LINDA C. SAWYER Hoechst Celanese Corporation Summit, NJ USA and DAVID T. GRUBB Cornell University Ithaca, NY USA CHAPMAN & HALL London Glasgow Weinheim New York Tokyo
More informationRegistration and renewal of the credential certificate for registration
Registration and renewal of the credential certificate for registration 1. Qualification of the applicant: 1.1 Must be a holder of the license to manufacture or import the psychotropic substances of category
More informationCompounding Questions and Answers
Compounding Questions and Answers JANUARY 10, 2011 1. Question: What is a reliable supplier? Answer: Some examples of reliable suppliers are FDA licensed manufacturers, CA Department of Public Health Food
More informationPolymer Matrix Composites
Polymer Matrix Composites Soviet Advanced Composites Technology Series Series editors: J. N. Fridlyander, Russian Academy of Sciences,, Russia 1. H. Marshall, University of Paisley, Paisley, UK This series
More informationHandbook of Paper & Paperboard Packaging Technology, 2nd Edition
Handbook of Paper & Paperboard Packaging Technology, 2nd Edition Table of Contents Contributors xv Preface xvii Acknowledgements xix 1 Paper and paperboard raw materials, processing and properties 1 Daven
More informationNotifications process: requests to vary registered medicines where quality, safety and efficacy are not affected
Notifications process: requests to vary registered medicines where quality, safety and efficacy are not affected Version 1.0, June 2017 (pending legislative amendments) 8 June 2017 For information only.
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 17 December 2003 CPMP/QWP/122/02, rev 1 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) GUIDELINE
More informationWorking document QAS/ June 2011 RESTRICTED DRAFT FOR COMMENT
June 2011 RESTRICTED DRAFT PROPOSAL FOR Revision of General method in the 4th Edition of The International Pharmacopoeia 3.3 MICROBIAL PURITY OF PHARMACEUTICAL PREPARATIONS (June 2011) DRAFT FOR COMMENT
More informationLeachable and Extractable Testing
Leachable and Extractable Testing A Primer on Regulations and Methods As presented to By: Anthony Grilli, MS General Manager SGS LSS NJ Laboratory 973 244 2435 Anthony.Grilli@SGS.com Summary Why perform
More informationContainer Closure Integrity Testing Method Development and Validation for Pre lled Syringes
Container Closure Integrity Testing Method Development and Validation for Pre lled Syringes Lei Li Utilization of pr ringes as a preferred container closure system for biologics has been increasing [1].
More informationRetort Pouches 2015 to 2019
Section I: Section II: Introduction A. Retort pouch Retort Pouches 2015 to 2019 B. Study organization C. Geographic regions D. Methodology and organization E. Conventions Executive Summary A. Technology
More informationTeeramanas Tanaekakarapong, a peritoneal dialysis patient
Teeramanas Tanaekakarapong, a peritoneal dialysis patient Application of ICHQ9 Risk Management Principles to Assess the Risk of Leachables Adversely Impacting the Quality and/or Safety of Complex Biopharmaceuticals
More informationCombination products Updates Final FDA Guidance
Compliance Seminars Combination products Updates Final FDA Guidance Presented by Anna Lundén Webinar, March 8, 2017 Intentionally blank Compliance Seminars Our international course program for GMP professionals
More informationFROM CLINICAL TO COMMERCIAL CUSTOM CAN. An overview of our Development and Manufacturing capabilities
FROM CLINICAL TO COMMERCIAL CUSTOM CAN An overview of our Development and Manufacturing capabilities THE CUSTOM DIFFERENCE Established in 1979, Custom Pharma Services has grown to become the go-to resource
More informationGUIDELINES FOR THE PACKAGING AND STORAGE OF PESTICIDES FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS
GUIDELINES FOR THE PACKAGING AND STORAGE OF PESTICIDES FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS - ii - GUIDELINES FOR THE PACKAGING AND STORAGE OF PESTICIDES FOOD AND AGRICULTURE ORGANIZATION
More information2-2 Sterile Product Assessment. Satish Mallya Ph.D Training Workshop CPH, May 2015
2-2 Sterile Product Assessment Satish Mallya Ph.D Training Workshop CPH, May 2015 Focus Overview of Regulatory Requirements Tips for Critical Thinking Issues and Solutions Regulatory Requirements - Overview
More informationPROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT
August 2010 RESTRICTED PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT Please address any comments on this draft guideline
More informationHARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS
HARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS QUALICAPS HISTORY Over one hundred years of experience in the manufacturing and filling of hard two-piece capsules Qualicaps originated within
More informationINTRODUCTION TO THE QUALITY SYSTEMS APPROACH TO CGMP COMPLIANCE
001_005.qxd 24/2/06 19:46 Page 1 CHAPTER 1 INTRODUCTION TO THE QUALITY SYSTEMS APPROACH TO CGMP COMPLIANCE 1.1 OVERVIEW OF QUALITY SYSTEMS The Food and Drug Administration (FDA) mandates that a drug firm,
More informationCMC Strategy Forum Europe 2016
Science-based Development & Licensing of Combination Products Focus on High Concentration Monoclonal Antibody Solutions in Prefilled Syringes or Prefilled Pens Serge Mathonet, Sanofi Global Regulatory
More informationOverview SFLGDP1. Develop, implement and maintain a quality system to control the distribution of medicinal products
Overview This standard is about developing, implementing and maintaining a quality system to control the. You will be responsible for developing the quality system and confirming colleagues understand
More informationCATEGORY Advertising. CATEGORY Biopharmaceutics. CATEGORY Biosimilarity
CATEGORY Advertising Guidance Agenda: New & Guidances CDER is Planning to Publish During Calendar Year 2016 (See the Good Guidance Practices (GGPs) regulation on this Web page or 21 CFR 10.115 for details
More informationRegistration Application form for Vaccines (To be submitted in duplicate electronic copies)
Cover letter addressed to: Registration Application form for Vaccines (To be submitted in duplicate electronic copies) THE CHIEF EXECUTIVE FOOD AND DRUGS AUTHORITY P. O. BOX CT 2783 CANTONMENTS-ACCRA GHANA.
More informationEUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS
EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible
More informationPharmaceutical Plastic Packaging
Our service spectrum for pharmaceutical plastic packaging Tailor-made solutions based on plastic www.gerresheimer.com...in many different...or individually and... specialised in...and with state-of-the-art
More informationAnnex A2. Guidance on Process Validation Scheme for Aseptically Processed Products
Annex A2 Guidance on Process Validation Scheme for Aseptically Processed Products 1 Table of content 1 PURPOSE... 3 2 SCOPE... 3 3 GENERAL INFORMATION... 3 4 INFORMATION NEEDED FOR ASEPTIC PROCESSES VALIDATION...
More informationCollege ter Beoordeling van Geneesmiddelen (CBG) Medicines Evaluation Board (MEB) Graadt van Roggenweg AH Utrecht The Netherlands
MEB agency / Veterinary Medicinal Products Unit The Netherlands C B G M E B College ter Beoordeling van Geneesmiddelen (CBG) Medicines Evaluation Board (MEB) Graadt van Roggenweg 500 3531 AH Utrecht The
More informationGUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY
GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY 2017 GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY 2017 Copyright 2017 by British Compressed Gases Association. First printed 2017. All rights reserved. No
More information3M Drug Delivery Systems. April 26, 2011
3M MDI Manufacturing April 26, 2011 3M Drug Delivery Systems Drug Delivery Systems Overview 3M Drug Delivery Systems is a division of 3M that is dedicated to the development and manufacturing of inhalation
More informationEN Official Journal of the European Union. (Acts whose publication is obligatory) COMMISSION REGULATION (EC) No 1084/2003.
L 159/1 I (Acts whose publication is obligatory) COMMISSION REGULATION (EC) No 1084/2003 of 3 June 2003 concerning the examination of variations to the terms of a marketing authorisation for medicinal
More informationGlobal Regulatory Affairs
Navigating the Regulatory Landscape for Combination Products Presented by: Becky Leibowitz, Ph.D. Associate Director, RA-CMC, Medical Devices & Combination Products Janssen Research & Development, LLC
More informationGuidance for Industry
Guidance for Industry Cooperative Manufacturing Arrangements for Licensed Biologics Additional copies of this guidance are available from the Office of Communication, Training and Manufacturers Assistance
More informationThe Device Side of Combination Products
The Device Side of Combination Products Technical and Regulatory Challenges in Life Cycle Management Bob Laughner Associate Director, Combination Products 04 May 2016 What are combination products? Combination
More informationMODULE 2.3 QUALITY OVERALL SUMMARY PRODUCT DOSSIER (QOS PD)
MODULE 2.3 QUALITY OVERALL SUMMARY PRODUCT DOSSIER () INTRODUCTION The introduction should include proprietary name, non-proprietary name or common name of the drug substance, company name, dosage form(s),
More informationIngredient Listing Qty. Unit NDC # Supplier. 1.0 Bottle
7/26/2018; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier (Powder), USP 120 mg Bottle 1.00 Bottle Oral Mix Dry Alka, SF (Unflavored) 3.8 g Bottle 1.0 Bottle Purified Water, USP
More informationISO Part 1 and Part 2 Compliance Requirements. Cathriona O Neill
ISO 11607 Part 1 and Part 2 Compliance Requirements Cathriona O Neill I.S. EN 11607 Introduction ISO 11607 is the principal guidance document. Packaging for terminally sterilised medical devices - Part
More informationPublic Assessment Report Scientific discussion. Paxiflas 37.5 mg/325 mg Orodispersible Tablets (Tramadol hydrochloride / Paracetamol)
Public Assessment Report Scientific discussion Paxiflas 37.5 mg/325 mg Orodispersible Tablets (Tramadol hydrochloride / Paracetamol) Registration number in Spain:xxx EU-procedure number: ES/H/0331/001/DC
More informationThis document is meant purely as a documentation tool and the institutions do not assume any liability for its contents
2006R2023 EN 17.04.2008 001.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COMMISSION REGULATION (EC) No 2023/2006 of 22
More informationOverview of Regulatory Requirements for API and Formulations
Overview of Regulatory Requirements for API and Formulations Sangeeta Sardesai 4-Dec-2010 Definition - Regulatory Requirement The restrictions, licenses, and laws applicable to a product or business, imposed
More informationScalable Strategies for Parenteral Dosage Form Selection
Scalable Strategies for Parenteral Dosage Form Selection Tony Pidgeon Process Technology Director Pharma Services Patheon, part of Thermo Fisher Scientific There are many parenteral dosage forms from which
More information